Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo W Langer

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Diagnostics (Basel, Switzerland)|July 27, 2022
Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279Tine N Christensen, Seppo W Langer, Gitte Persson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2018
A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Journal of Neuroendocrinology|June 25, 2026
Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids"Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung CancerTine N Christensen, Seppo W Langer, Gitte Persson, et al.
Case Reports in Medicine|January 23, 2016
Cowden Syndrome and Concomitant Pulmonary Neuroendocrine Tumor: A Presentation of Two CasesSeppo W Langer, Lene Ringholm, Christine I Dali, et al.
Acta Oncologica (Stockholm, Sweden)|March 29, 2021
A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)Isak T Laenkholm, Seppo W Langer, Mikkel Andreassen, et al.
Frontiers in Immunology|December 29, 2022
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancerHeidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2011
First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experienceIngrid Holst Olsen, Seppo W Langer, Ida Jepsen, et al.
Journal of Neuroendocrinology|March 19, 2026
Follow-up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi-ENETS Center of Excellence StudyTobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Ugeskrift for Laeger|October 5, 2016
[Cardiovascular complications following thoracic radiotherapy in patients with cancer]Kirsten Melgaard Nielsen, Julie I Helene Borchsenius, Birgitte Vrou Offersen, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Diagnostics (Basel, Switzerland)|July 27, 2022
Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279Tine N Christensen, Seppo W Langer, Gitte Persson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2018
A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Journal of Neuroendocrinology|June 25, 2026
Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids"Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung CancerTine N Christensen, Seppo W Langer, Gitte Persson, et al.
Case Reports in Medicine|January 23, 2016
Cowden Syndrome and Concomitant Pulmonary Neuroendocrine Tumor: A Presentation of Two CasesSeppo W Langer, Lene Ringholm, Christine I Dali, et al.
Acta Oncologica (Stockholm, Sweden)|March 29, 2021
A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)Isak T Laenkholm, Seppo W Langer, Mikkel Andreassen, et al.
Frontiers in Immunology|December 29, 2022
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancerHeidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2011
First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experienceIngrid Holst Olsen, Seppo W Langer, Ida Jepsen, et al.
Journal of Neuroendocrinology|March 19, 2026
Follow-up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi-ENETS Center of Excellence StudyTobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Ugeskrift for Laeger|October 5, 2016
[Cardiovascular complications following thoracic radiotherapy in patients with cancer]Kirsten Melgaard Nielsen, Julie I Helene Borchsenius, Birgitte Vrou Offersen, et al.
Pageof 12